Galapagos NV (XBRU:GLPG)
€ 15.99 0 (0%) Market Cap: 1.73 Bil Enterprise Value: -1.60 Bil PE Ratio: 8.38 PB Ratio: 0.60 GF Score: 55/100

Galapagos NV at ASH Meeting & Exposition Transcript

Dec 10, 2023 / 07:00PM GMT
Sofie Van Gijsel
Galapagos NV - Head of IR

Welcome, everyone, and thank you for joining Galapagos here in San Diego or virtually for our KOL event following yesterday's presentation at ASH of our ongoing Phase I/II EUPLAGIA study in CLL and Richter transformation and our ATALANTA study in NHL.

I would like to remind everyone that we will be making forward-looking statements during today's webcast. These forward-looking statements include remarks concerning future developments of the pipeline and our company and possible changes in the industry and competitive environments. Because these forward-looking statements involve risks and uncertainties, Galapagos' actual results may differ materially from the results expressed or implied in these statements.

Today's speakers for Galapagos will be Dr.Paul A. Stoffels, CEO and Chairman; and Dr. Jeevan Shetty, Head of Clinical Development Oncology.

We are very pleased that we are joined today by 4 key opinion leaders in the field: Professor Davids of the Dana Farber Cancer Institute and Professor Ghia of the University of Milan will

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot